DellD., ChamberlainJ., CoppinF.Determination ofcefotaxime and desacetyl-cefotaxime in plasma and urine by high-performance liquid chromatography.J Chromatogr.1981; 226: 431–440.
2.
AlbinH.C., Demotes-MainardF.M., BouchetJ.L.Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.Clin Pharmacol Ther.1985; 38: 285–289.
3.
HasegawaH., ImadaA., HoriuchiA.Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.J. Antimicrobial Chemother.1984; 14(Suppl B): 135–142.
HeimK.L., HalstensonC.E., ComptyC.M.Pharma-cokinetics of cefotaxime during CAPD. In: MaherJ.F., WinchesterJ.F., eds. Frontiers in peritoneal dialysis.New York: Field, Rich and Ass.; 1986: 125–130.
6.
PetersenJ., StewartR.D.M., Cat toG.R.D.Pharmaco-kinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.Nephron.1985; 40: 79–82.
